As previously elucidated, these biochemical differences among individuals in terms of SA and CD147, together with the related RBC evolutionary changes, could partly explain the reduced pathogenicity of COVID-19 in those countries where malaria and sickle cell disease are more endemic. Here, BSG is linked to COVID-19.